Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Photochem Photobiol. 2012 Oct 12;89(1):2–4. doi: 10.1111/j.1751-1097.2012.01233.x

Killing Bacterial Spores with Blue Light: When Innate Resistance Meets the Power of Light

Tyler G St Denis 1,2, Tianhong Dai 2,3, Michael R Hamblin 2,3,4,*
PMCID: PMC3556167  NIHMSID: NIHMS434440  PMID: 22946878

Abstract

This article is a highlight of the study by Maclean et al. in this issue of Photochemistry and Photobiology describing the sporicidal effects 405 nm visible light alone on endospores of the Clostridium and Bacillus genera. 1.73 kJ cm−2 was capable of reducing endospore colony-forming units by up to 4-log10. These findings have never been previously demonstrated and may be incorporated into decontamination methods that span medical, military and food preparatory applications.

INTRODUCTION

Since the discovery of bacterial endospores by Tyndall, Cohn and Koch in the late 1800s, spores have been heralded as the hardiest biological entities on earth (1). Microbial life first appeared on earth over 3.5 billion years ago, and microbes therefore evolved in extremely harsh environmental conditions. One subsection of Gram-positive Firmicutes, the low (G + C) Gram-positive bacteria, evolved the ability to endosporulate so as to lie dormant until environmental conditions favored germination and subsequent replication (2).

Microbial endospores are capable of withstanding excessive physical insults including heat, ionizing (ultraviolet and gamma) radiation, osmotic pressure and desiccation. The extreme resistance conferred by spores protects them from chemical and biological disinfectants such as iodine, peroxides, alkylating agents, formaldehyde and glutaraldehyde (1). Although this is biologically fascinating, endospore-forming bacteria are a formidable threat in medicine. A list of the most dangerous spore forming bacteria and their respective threats to human health—all of which are found in the Clostridium or Bacillus genera, low (G + C) Gram-positive bacilli—is found in Table 1. Note that these species are notoriously resistant to conventional antibiotic modalities in addition to antiseptic techniques.

Table 1.

Medically relevant endospore-forming bacteria, and their respective abilities to cause diseases harmful to human health.

Endospore-forming bacterium Human health threat References
Bacillus anthracis Anthrax via the anthrax toxin (35)
Bacillus cereus Foodborne illness (36)
Clostridium botulinum Botulism via botulinum toxin (37)
Clostridium difficile Pseudomembranous colitis, toxic megacolon (38)
Clostridium perfringens Bacteremia, clostridial myonecrosis (gas gangrene), foodborne illness all via the C. perfringens alpha toxin (39)
Clostridium tetani Tetanus via tetanospasmin (40)

The extreme resistance of endospores is illustrated by the historical story of Gruinard Island, a remote island off the west coast of Scotland (3). Gruinard was the site of a biological warfare test by British military scientists from Porton Down in 1942, during the Second World War. It was recognized that the tests would cause widespread and long-lasting contamination of the immediate area by anthrax spores. To limit contamination, a remote and uninhabited island was required. Gruinard was surveyed, deemed suitable and compulsorily purchased from its owners by the British Government. Military scientists exploded a series of anthrax-spore laden bombs, testing their killing efficiency using sheep (4). Initial efforts to decontaminate the island after the biological warfare trials had ended, failed due to the high durability of anthrax spores. For many years it was judged too hazardous and expensive to decontaminate the island sufficiently to allow public access. Gruinard Island was quarantined indefinitely as a result. Visits to the island were prohibited, except for periodic checks by Porton Down personnel to determine the level of contamination. Starting in 1986 (44 years later) a determined effort was made to decontaminate the island, with 280 tonnes of formaldehyde diluted in seawater being sprayed over all 196 hectares of the island and the worst-contaminated topsoil around the dispersal site being physically removed (5). A flock of sheep was then placed on the island and remained healthy (6).

The intentional attacks by anthrax-spore laden mailed envelopes in the US in the fall of 2001 led to a large international effort to investigate methods of decontaminating bacillus spores (7). In situ generated chlorine dioxide gas was determined to be the best method for buildings and inanimate surfaces (8).

In a 2005 landmark publication by Demidova and Hamblin (9), photodynamic therapy, previously shown to be ineffective in the removal of Bacillus spores, effectively and efficiently reduced Bacillus spore colony-forming units by 5 to 6-log10 provided phenothiazinium photosensitizers (50 μM toluidine blue O incubated for 3 h and followed by 20 J cm−2 red light) were used. This finding demonstrated that, despite the high resistance to chemical stressors, Bacillus spores are susceptible to destruction by reactive oxygen species (ROS) including partially reduced oxygen species such as the hydroxyl radical or superoxide radical anion and the nonradical species, excited singlet state oxygen.

Up until now, all physical methods of destroying endospores (e.g. heat, radiation, etc.) have been relatively ineffective, and the application of electromagnetic radiation in the destruction of endospores was, as documented by Demidova and Hamblin, was absolutely dependent on the addition of an exogenous photosensitizer. In this issue of Photochemistry and Photobiology, work by Maclean et al. of the University of Strathclyde in Glasgow, Scotland has demonstrated (10) that high-intensity, nonionizing blue light is capable of destroying Bacillus and Clostridium endospores with an impressive reduction of 4 log10 colony-forming units. Testing 1.73 kJ cm−2 of 405 nm light, Maclean’s team was able to inactivate B. cereus, B. megaterium, B. subtilis and C. difficile endospores. It is important to note that Demidova and Hamblin’s photoinactivation procedures were incapable of killing B. megaterium. Maclean also verified that their high-intensity light technique does not encourage endospore germination. The efficacy of this 405 nm therapy may be explained by the presence of endogenous porphyrins such as coproporphyrin with Soret bands in the 400–420 nm regions of the visible spectrum in Bacillus and Clostridium bacteria (1113). Thus, the sporicidal effect of blue light is probably an oxygen-dependent process akin to the light-mediated destruction of Helicobacter pylori and Propionobacterium acnes—a photodynamic inactivation relying on pathogen’s biosynthesis of endogenous photosensitizers (14, 15). The mechanisms of blue light spore inactivation and photodynamic therapy (PDT) spore inactivation is probably fairly similar, especially when the PDT is mediated by porphyrins and other tetrapyrroles that mainly produce singlet oxygen. In case of other photosensitizers that produce hydroxyl radicals, the mechanisms may have some differences.

Blue light has recently attracted much attention as an alternative antimicrobial approach (16) due to its intrinsic antimicrobial properties without the involvement of added exogenous photosensitizers (17). Blue light can be sensed by numerous microorganisms and can induce physiological responses elicited by blue light receptors (18). As a result of this, blue light can regulate bacterial motility, suppress biofilm formation and potentiate light inactivation of bacteria. On the other hand, the presence of blue light may also up-regulate bacterial virulence factors (19).

Studies have found that blue light inactivation of bacteria is oxygen dependent (20, 21), suggesting that the antimicrobial effect of blue light is associated with the photoexcitation of intracellular chromophores and the subsequent generation of cytotoxic ROS such as singlet oxygen. Intracellular photosensitizing porphyrins were found in P. acnes (22), H. pylori (23) and some oral bacteria (24). Different porphyrin patterns were observed in different bacteria.

Blue light therapy is now an accepted protocol for acne vulgaris (2528), and additional clinical trials have been carried out using blue light for H. pylori gastritis showing promising outcomes (14, 29). Blue light may also be effective in oral infections by killing dental anaerobic bacterial species.

In comparison to PDT, blue light inactivates bacteria without the involvement of exogenous photosensitizer. As a result, the use of blue light inactivation is technically easier to carry out. Delivery of photosensitizers to the target microbes embedded deep within tissue has been somewhat challenging when PDT is used for infectious diseases. One question that will have to be addressed is “Can microbial cells develop resistance to blue light inactivation?” To our knowledge, this question has not yet been experimentally addressed. The possible development of microbial resistance to photodynamic inactivation has been studied. After repeated cycles of partial inactivation followed by regrowth, different bacterial species failed to develop resistance to the photodynamic process after 10 (30) or even 20 cycles (31). At the very least, it will be necessary to repeatedly deliver suberadication doses of blue light to susceptible cultures with regrowth between cycles to investigate whether resistant clones can be selected, or mutants with increased blue light damage repairing enzymes can be produced.

Although the amount of light energy needed to kill endospores in Maclean’s study was 10-fold the Joule output needed to kill vegetative B. cereus and C. difficile, and is also considered too intense for therapeutic purposes, the light-mediated killing of endospores is of considerable antiseptic and decontamination interest. High-intensity 405 nm light may have application in the medical, military and agricultural fields to combat B. anthracis spore exposure. B. anthracis is known to have endospores of comparable robustness to B. cereus and B. subtilis; noting the findings of this study, 405 nm light may find application in the removal of B. anthracis from medical and military devices (3234). Simple speculation suggests several applications of sporicidal high-intensity 405 nm light: hospital rooms may be decontaminated of C. difficile and C. perfringens spores, agricultural products and tools may be cleaned of C. tetani and C. botulinum and food preparatory devices may be disinfected of B. cereus.

Acknowledgments

T. G. St Denis was supported by the Columbia University I. I. Rabi Science Research Fellowship. T. Dai was supported by an Airlift Research Foundation Extremity Trauma Research grant #109421, and an Orthopaedic Trauma Association Basic Research grant 2012 #16. M. R. Hamblin was supported by NIH grant RO1AI050875.

References

  • 1.Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev. 2000;64:548–572. doi: 10.1128/mmbr.64.3.548-572.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Onyenwoke RU, Brill JA, Farahi K, Wiegel J. Sporulation genes in members of the low G + C Gram-type-positive phylogenetic branch (Firmicutes) Arch Microbiol. 2004;182:182–192. doi: 10.1007/s00203-004-0696-y. [DOI] [PubMed] [Google Scholar]
  • 3.Willis EA. Landscape with dead sheep: What they did to Gruinard Island. 2002. Med Confi Surviv. 2009;25:320–331. doi: 10.1080/13623690903417382. [DOI] [PubMed] [Google Scholar]
  • 4.Manchee RJ, Broster MG, Melling J, Henstridge RM, Stagg AJ. Bacillus anthracis on Gruinard Island. Nature. 1981;294:254–255. doi: 10.1038/294254a0. [DOI] [PubMed] [Google Scholar]
  • 5.Manchee RJ, Broster MG, Stagg AJ, Hibbs SE. Formaldehyde solution effectively inactivates spores of Bacillus anthracis on the Scottish Island of Gruinard. Appl Environ Microbiol. 1994;60:4167–4171. doi: 10.1128/aem.60.11.4167-4171.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Aldhous P. Biological warfare. Gruinard Island handed back. Nature. 1990;344:801. doi: 10.1038/344801b0. [DOI] [PubMed] [Google Scholar]
  • 7.Spotts Whitney EA, Beatty ME, Taylor TH, Jr, Weyant R, Sobel J, Arduino MJ, Ashford DA. Inactivation of Bacillus anthracis spores. Emerg Infect Dis. 2003;9:623–627. doi: 10.3201/eid0906.020377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Rastogi VK, Ryan SP, Wallace L, Smith LS, Shah SS, Martin GB. Systematic evaluation of the efficacy of chlorine dioxide in decontamination of building interior surfaces contaminated with anthrax spores. Appl Environ Microbiol. 2010;76:3343–3351. doi: 10.1128/AEM.02668-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Demidova TN, Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol. 2005;71:6918–6925. doi: 10.1128/AEM.71.11.6918-6925.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Maclean M, Murdoch LE, Macgregor SJ, Anderson JG. Sporicidal effects of high-intensity 405 nm visible light on endospore-forming bacteria. Photochem Photobiol. 2012 doi: 10.1111/j.1751-1097.2012.01202.x. [DOI] [PubMed] [Google Scholar]
  • 11.Griego VM, Spence KD. Inactivation of Bacillus thuringiensis spores by ultraviolet and visible light. Appl Environ Microbiol. 1978;35:906–910. doi: 10.1128/aem.35.5.906-910.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Harms RL, Martinez DR, Griego VM. Isolation and characterization of coproporphyrin produced by four subspecies of Bacillus thuringiensis. Appl Environ Microbiol. 1986;51:481–486. doi: 10.1128/aem.51.3.481-486.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hamblin MR, Mróz P. Advances in Photodynamic Therapy: Basic, Translational, and Clinical. Artech House; 2008. [Google Scholar]
  • 14.Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A, Tolkoff MJ, Nishioka NS, Hamblin MR. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med. 2005;36:260–265. doi: 10.1002/lsm.20161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fan X, Xing YZ, Liu LH, Liu C, Wang DD, Yang RY, Lapidoth M. Effects of 420-nm intense pulsed light in an acne animal model. J Eur Acad Dermatol Venereol. 2012 doi: 10.1111/j.1468-3083.2012.04487.x. [DOI] [PubMed] [Google Scholar]
  • 16.Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9:894–896. doi: 10.1038/nrmicro2693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat. 2012;15 doi: 10.1016/j.drup.2012.07.001. (Epub ahead of print) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Losi A, GW Old chromophores, new photoactivation paradigms, trendy applications: Flavins in blue light-sensing photoreceptors. Photochem Photobiol. 2011;87:491–510. doi: 10.1111/j.1751-1097.2011.00913.x. [DOI] [PubMed] [Google Scholar]
  • 19.Gomelsky M, Hoff WD. Light helps bacteria make important lifestyle decisions. Trends Microbiol. 2010;19:441–448. doi: 10.1016/j.tim.2011.05.002. [DOI] [PubMed] [Google Scholar]
  • 20.Maclean M, Macgregor SJ, Anderson JG, Woolsey GA. The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol, B. 2008;92:180–184. doi: 10.1016/j.jphotobiol.2008.06.006. [DOI] [PubMed] [Google Scholar]
  • 21.Feuerstein O, Ginsburg I, Dayan E, Veler D, Weiss EI. Mechanism of visible light phototoxicity on Porphyromonas gingivalis and Fusobacterium nucleatum. Photochem Photobiol. 2005;81:1186–1189. doi: 10.1562/2005-04-06-RA-477. [DOI] [PubMed] [Google Scholar]
  • 22.Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. 2003;35:17–24. doi: 10.1111/j.1574-695X.2003.tb00644.x. [DOI] [PubMed] [Google Scholar]
  • 23.Hamblin MR, Viveiros J, Yang C, Ahmadi A, Ganz RA, Tolkoff MJ. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother. 2005;49:2822–2827. doi: 10.1128/AAC.49.7.2822-2827.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Soukos NS, Som S, Abernethy AD, Ruggiero K, Dunham J, Lee C, Doukas AG, Goodson JM. Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother. 2005;49:1391–1396. doi: 10.1128/AAC.49.4.1391-1396.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: An open study and in vitro investigation. J Dermatol Sci. 2002;30:129–135. doi: 10.1016/s0923-1811(02)00068-3. [DOI] [PubMed] [Google Scholar]
  • 26.Noborio R, Nishida E, Kurokawa M, Morita A. A new targeted blue light phototherapy for the treatment of acne. Photodermatol Photoimmunol Photomed. 2007;23:32–34. doi: 10.1111/j.1600-0781.2007.00268.x. [DOI] [PubMed] [Google Scholar]
  • 27.Ammad S, Gonzales M, Edwards C, Finlay AY, Mills C. An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris. J Cosmet Dermatol. 2008;7:180–188. doi: 10.1111/j.1473-2165.2008.00386.x. [DOI] [PubMed] [Google Scholar]
  • 28.Wheeland RG, Dhawan S. Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. J Drugs Dermatol. 2011;10:596–602. [PubMed] [Google Scholar]
  • 29.Lembo AJ, Ganz RA, Sheth S, Cave D, Kelly C, Levin P, Kazlas PT, Baldwin PC, 3rd, Lindmark WR, McGrath JR, Hamblin MR. Treatment of Helicobacter pylori infection with intragastric violet light phototherapy: A pilot clinical trial. Lasers Surg Med. 2009;41:337–344. doi: 10.1002/lsm.20770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Tavares A, Carvalho CM, Faustino MA, Neves MG, Tomé JP, Tomé AC, Cavaleiro JA, Cunha A, Gomes NC, Alves E, Almeida A. Antimicrobial photodynamic therapy: Study of bacterial recovery viability and potential development of resistance after treatment. Mar Drugs. 2010;8:91–105. doi: 10.3390/md8010091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Giuliani F, Martinelli M, Cocchi A, Arbia D, Fantetti L, Roncucci G. In vitro resistance selection studies of RLP068/Cl, a new Zn (II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob Agents Chemother. 2010;54:637–642. doi: 10.1128/AAC.00603-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, Mock M, Hegna I, Kolsto AB. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis—One species on the basis of genetic evidence. Appl Environ Microbiol. 2000;66:2627–2630. doi: 10.1128/aem.66.6.2627-2630.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sagripanti JL, Carrera M, Insalaco J, Ziemski M, Rogers J, Zandomeni R. Virulent spores of Bacillus anthracis and other Bacillus species deposited on solid surfaces have similar sensitivity to chemical decontaminants. J Appl Microbiol. 2007;102:11–21. doi: 10.1111/j.1365-2672.2006.03235.x. [DOI] [PubMed] [Google Scholar]
  • 34.Nicholson WL, Galeano B. UV resistance of Bacillus anthracis spores revisited: Validation of Bacillus subtilis spores as UV surrogates for spores of B. anthracis Sterne. Appl Environ Microbiol. 2003;69:1327–1330. doi: 10.1128/AEM.69.2.1327-1330.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Plaut RD, Kelly VK, Lee GM, Stibitz S, Merkel TJ. A dissemination bottleneck in murine inhalational anthrax. Infect Immun. 2012 doi: 10.1128/IAI.00515-12. (Epub ahead of print) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rogers TE, Ataide SF, Dare K, Katz A, Seveau S, Roy H, Ibba M. A pseudo-tRNA modulates antibiotic resistance in Bacillus cereus. PLoS ONE. 2012;7:e41248. doi: 10.1371/journal.pone.0041248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pontes HA, Pontes FS, de Oliveira GF, de Almeida HA, Guimaraes DM, Cavallero FC. Uncommon foreign body reaction caused by botulinum toxin. J Craniofac Surg. 2012;23:e303–e305. doi: 10.1097/SCS.0b013e318252f3e0. [DOI] [PubMed] [Google Scholar]
  • 38.Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K. A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings. Jpn J Infect Dis. 2012;65:326–329. doi: 10.7883/yoken.65.326. [DOI] [PubMed] [Google Scholar]
  • 39.Lindstrom M, Heikinheimo A, Lahti P, Korkeala H. Novel insights into the epidemiology of Clostridium perfringens type A food poisoning. Food Microbiol. 2011;28:192–198. doi: 10.1016/j.fm.2010.03.020. [DOI] [PubMed] [Google Scholar]
  • 40.Poudel P, Budhathoki S, Manandhar S. Tetanus. Kathmandu Univ Med J (KUMJ) 2009;7:315–322. [PubMed] [Google Scholar]

RESOURCES